Nursing and Health Professions
Antiinfective Agent
87%
Hospital
81%
Error
46%
Drug Therapy
37%
Antimicrobial Resistance
28%
Self Evaluation
26%
Hospital Pharmacy
24%
Antimicrobial Stewardship
24%
Patient
24%
Pharmacy
23%
Procedures
22%
Data Base
21%
Respiratory Tract Infection
20%
Nurse
20%
Reactive Oxygen Metabolite
20%
Economic Evaluation
18%
Point of Care Testing
17%
C Reactive Protein
16%
Clinical Pharmacy
12%
Practice Guideline
10%
Socialized Medicine
10%
Intravenous Drug Administration
10%
Clinical Audit
10%
Time
9%
Symptom
9%
Teaching Hospital
8%
Wound Healing
8%
Primary Medical Care
8%
Advisory Committee
8%
Medical Specialist
8%
Health Economics
7%
Confidence Interval
6%
Diagnosis
6%
Hospital Department
6%
Clotiazepam
6%
Drug
5%
Systematic Review
5%
Health Care Personnel
5%
Publication
5%
Obstetric Delivery
5%
Hydrogen Peroxide
5%
Validity
5%
Sample
5%
Analysis
5%
Wound
5%
Standard
5%
Cost Effectiveness Analysis
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antiinfective Agent
100%
Antibiotic Agent
26%
Infection
26%
Antibiotics
26%
Reactive Oxygen Metabolite
24%
Wound
23%
Antimicrobial Resistance
21%
Clostridium Difficile Infection
13%
Amphotericin B
12%
Intervention Trial
12%
Pharmacoeconomics
12%
Hospital Pharmacy
12%
Cefotaxime
12%
Lipid
10%
Organisms
10%
Hexachlorophene
9%
Cephalosporin Derivative
7%
Ulcer
6%
Antimicrobial Resistance
6%
Pharmacoepidemiology
6%
Bioburden
5%
Indicator
5%
Gram Negative Bacterium
5%
Quinolone Derivative
5%
Antibiotic Resistance
5%
Medicine and Dentistry
Antiinfective Agent
56%
Wound
20%
Antimicrobial Activity
20%
Health Care Cost
15%
Antibiotics
13%
Antibiotic Resistance
13%
Respiratory Tract Infection
11%
Anti-biotics
9%
Hexachlorophene
9%
Wound Healing
8%
Patient
7%
Infection
7%
Primary Health Care
7%
Inpatient
7%
In Vitro
7%
C Reactive Protein
6%
Self-Diagnosis
6%
Venous Ulcer
6%
Wound Care
6%
Chemotherapy
6%
Staphylococcus Aureus
5%
Hospital
5%
Drug
5%
Chemotherapeutic Agent
5%
Gram-Negative Bacteria
5%
Hydrogen Peroxide
5%
Athletic Training
5%
Assessment
5%
Development
5%
